(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

ZENIT

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

ZENIT

ST13

US500000079193284

Class

9, 10

Filing

79193284

Registration

5326360

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

37

Latest update

06/01/2025

Trademark type

Combined

Nice classes

9, 10

Filing date

06/07/2016

Registration date

11/07/2017

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

05/24/2024

Last transaction

06/01/2025

Responsible office

United States Patent and Trademark Office

Status code

709

Official register

Principal Register

Drawing code

3

Owner type

99

Owner location

IT

Examiner

LAVACHE, LINDA

Law office

L60

Current location

PUBLICATION AND ISSUE SECTION

Mark description

The mark consists of the word "ZENIT" where all of the letters are grey, except for the letter "E", which is formed by three horizontal lines, where the top line is blue, the middle line is grey, and the bottom line is green. The middle line is shorter than the top and bottom lines.

Holders and representatives

Holders

A. MENARINI INDUSTRIE FARMACEUTICHE RIUNITE S.r.l.

Representatives

Matthew D. Asbell Ladas & Parry LLP

Technical classification

Nice Classes

Class 9Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Diagnostic apparatus for laboratory or research use for automatically reading and interpreting specimens by indirect immunofluorescence on cell substrates; diagnostic equipment for scientific or laboratory usefor detecting antibodies; diagnostic apparatus for the detection of antibodies for laboratory or scientific research use; diagnostic equipment for scientific or laboratory usemicroplate and glass slide processors; diagnostic equipment for scientific or laboratory usemicroplate readers; diagnostic equipment for scientific or laboratory useplatesglass slides and chips having multi-well arrays that can be used in chemical analysis and biological analysis for patterning; diagnostic apparatus for automatically reading and interpreting specimens by indirect immunofluorescence on cell substratesthe diagnostic apparatus having as an integral componentpreloaded software that enables image capture and storageimmunofluorescence detectionpattern recognitionautomated analysis; diagnostic equipment for scientific or laboratory use for detecting antibodiesthe diagnostic equipment having as an integral componentpreloaded software for automating enzyme linked immunosorbent assayimmunofluorescence assay and microarray methods; diagnostic apparatus for automatically reading and interpreting specimens by indirect immunofluorescence on cell substratesthe diagnostic apparatus having as an integral componentpreloaded software for the detection of antibodies for laboratory or research use; diagnostic equipment for scientific or laboratory usemicroplate processors and glass slide processorsthe diagnostic equipment having as an integral componentpreloaded software for automating enzyme linked immunosorbent assayimmunofluorescence assay and microarray methods

Class 10

Medical apparatus for automatically diagnosingreading and interpreting specimens by indirect immunofluorescence on cell substrates; medical diagnostic apparatus for the detection of antibodies in autoimmune diseases; medical diagnostic instruments for the analysis of blood and body fluids; immunological analyzers for medical diagnostic purposes; medical apparatus for automatically diagnosingreading and interpreting specimens by indirect immunofluorescence on cell substratesthe medical apparatus having as an integral componentpreloaded software that enables image capture and storageimmunofluorescence detectionpattern recognitionautomated analysis; medical diagnostic apparatus for the detection of antibodies in autoimmune diseasesthe medical diagnostic apparatus having as an integral componentpreloaded software for the detection of antibodies in autoimmune diseases; medical diagnostic instruments for the analysis of blood and body fluidsthe medical diagnostic instruments having as an integral componentpreloaded software for the analysis of blood and body fluids; immunological analyzers for medical diagnostic purposesthe immunological analyzers having as an integral component preloaded software for detecting immune system components; hematology analyzers for medical diagnostic purposesthe hematology analyzers having as an integral component preloaded software for blood cell analysis

Publications

History of USPTO decisions and trademark events.

37 publications found

INNT

TOTAL INVALIDATION PROCESSED BY THE IB

05/31/2025

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

03/29/2025

XXCR

GENERIC MADRID TRANSACTION CREATED

03/29/2025

INTR

TOTAL INVALIDATION OF REG EXT PROTECTION CREATED

01/24/2025

C71T

CANCELLED SECTION 71

05/24/2024

REM3

COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED

11/07/2022

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

04/13/2018

XXSS

GENERIC MADRID TRANSACTION SENT TO IB

02/14/2018

XXCR

GENERIC MADRID TRANSACTION CREATED

02/14/2018

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

02/07/2018

R.PR

REGISTERED-PRINCIPAL REGISTER

11/07/2017

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

08/22/2017

PUBO

PUBLISHED FOR OPPOSITION

08/22/2017

GPNX

NOTIFICATION PROCESSED BY IB

08/18/2017

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

08/02/2017

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

08/02/2017

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/02/2017

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/14/2017

XAEC

EXAMINER'S AMENDMENT ENTERED

07/14/2017

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/14/2017

GNEA

EXAMINERS AMENDMENT E-MAILED

07/14/2017

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/14/2017

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

06/07/2017

CNFR

FINAL REFUSAL MAILED

05/03/2017

CNFR

FINAL REFUSAL WRITTEN

05/03/2017

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

04/13/2017

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

04/13/2017

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

04/13/2017

RFNT

REFUSAL PROCESSED BY IB

11/25/2016

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

11/09/2016

RFRR

REFUSAL PROCESSED BY MPU

11/09/2016

MAFR

APPLICATION FILING RECEIPT MAILED

10/18/2016

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

10/16/2016

CNRT

NON-FINAL ACTION WRITTEN

10/15/2016

DOCK

ASSIGNED TO EXAMINER

10/12/2016

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

10/12/2016

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

10/06/2016

Continuous trademark protection

Get notified about every new filing that threatens ZENIT or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.